![Brian P. Kearney](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Brian P.
Kearney worked as Vice President-Clinical Research at Gilead Sciences, Inc. from 2016 to 2020.
He also worked as Chief Development Officer at Pardes Biosciences, Inc. from 2020 to 2023.
Kearney earned a doctorate degree from UIC College of Pharmacy.
Antiguos cargos conocidos de Brian P. Kearney.
Empresas | Cargo | Fin |
---|---|---|
PARDES BIOSCIENCES, INC. | Corporate Officer/Principal | 15/05/2023 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/10/2020 |
Formación de Brian P. Kearney.
UIC College of Pharmacy | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Pardes Biosciences, Inc.
![]() Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Brian P. Kearney